According to the research report titled ‘GLOBAL Bariatric Surgery Market 2019-2028’, available with Market Study Report, global bariatric surgery market is slated to expand with a compound annual growth rate of 9.41% over the forecast period of 2019-2028.
 

As per credible research analysts, rising prevalence of chronic ailments such as heart diseases as well as diabetes coupled with escalating obesity rates are boosting global bariatric surgery market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552786/
 

Rising disposable incomes, innovative products launches, and tactical alliances such as acquisitions, mergers, and other strategic partnerships are further bolstering the industry expansion.
 

Additionally, ongoing technological advancements along with favorable government initiatives aimed at promoting the surgical procedures are positively swaying global bariatric surgery market dynamics.
 

Despite the positive outlook of the market, lack of awareness regarding the benefits of bariatric surgery, high costs associated with the process, and limited access to surgical care in emerging countries will continue to act as a blockade for the business development throughout the study period.
 

Regionally speaking, the overall industry is bifurcated into Middle East & Africa, Asia-Pacific, North America, Latin America, and Europe.
 

Among these, Asia-Pacific bariatric surgery market is anticipated to amass substantial gains through 2028. Favorable government initiatives aimed at reducing obesity rates, rising adoption of the surgical procedure in India and China, escalating research & development activities, and high concentration of prominent companies are fostering the regional market expansion.
 

Apollo Endosurgery Inc., Lupin Ltd., Olympus Corp., Ethicon Inc. (Johnson & Johnson), The Cooper Companies Inc., Reshape Lifesciences Inc., Intuitive Surgical Inc., GE Healthcare (General Electric Co.), Aspire Bariatrics Inc., Medtronic plc, CONMED Corp., B. Braun Melsungen AG, Allergan plc, and Abbott Laboratories are the top companies operating in global bariatric surgery market sphere.